Two Republican state lawmakers are introducing a bill that would allow terminally ill patients in Wisconsin to try potentially life-saving drug still under federal review.

Three Wisconsin companies have agreed to stop manufacturing dietary supplements after a federal complaint alleged the products were misbranded, according to the U.S. Department of Justice.

Wisconsin will receive $677,491.66 of a $35 million settlement with Wyeth Pharmaceuticals Inc. and its parent company, Pfizer Inc., after Wyeth was accused of unlawfully promoting a drug, according to a news release from Attorney General J.B. Van Hollen’s office.

Wisconsin will receive $200,000 for its Medicaid program from the settlement of a multi-state lawsuit accusing a pharmaceutical company of improperly marketing a drug.

After two high court terms full of high-profile cases ranging from the constitutionality of the Affordable Care Act to the fate of same-sex marriage laws, no one is calling the upcoming term a blockbuster. But perhaps they should be.

Wisconsin's Medicaid program will recoup more than $8,000 in a nationwide settlement resulting from a whisteblower action filed in federal court.

When Kerri and Brian Kaley came under federal investigation for allegedly stealing medical devices, they took out a $500,000 line of credit on their New York house to hire lawyers. Yet after their indictment in 2007, prosecutors sought to prevent the Kaleys from using the money because the government intended to seize the house.

The U.S. Supreme Court’s decision barring state-law design-defect claims against generic drug makers that mirror failure-to-warn actions served a major setback to plaintiffs seeking damages for drug injuries.

Mark Dahlby envisioned a very different career as he approached the end of law school in 2005.

A mass tort is taking shape over the Mirena IUD, a device that many women claim migrates after insertion and becomes embedded in the uterus or punctures organs, requiring surgical removal and sometimes causing infection and other injuries.

Deciding where the preemptive effect of federal rules governing drug manufacturing ends and states’ ability to impose liability on drug makers begins has never been an easy task — not even for the justices of the U.S. Supreme Court.

A Winnebago County couple has filed a lawsuit alleging that the side effects of Zoloft/sertraline use during pregnancy caused their infant to develop severe birth defects and die after birth.

Monster-brand energy drinks are marketed as being conventional carbonated beverages despite containing “dangerously high” amounts of caffeine, according to a new consumer class action filed in California federal court.

The increase in class-action litigation challenging labels on certain food products has consumer litigation attorneys taking notice, and laying at least part of the blame on federal regulators.

The state of Wisconsin stands to receive $9.6 million in the national settlement with pharmaceutical giant GlaxoSmithKline over federal and state complaints related to marketing and pricing of its drugs.

The parents of a 2-year-old who died after ingesting a fentanyl patch are suing a nursing home, claiming he picked the painkiller up there.

A $212 million verdict against Botox-maker Allergan will be retried because of improper hand gestures by the plaintiff’s attorney, who also allegedly broke the “golden rule” in closing arguments.

Johnson & Johnson plans to stop selling surgical mesh implants used to treat women's health problems, which have been linked to injuries and triggered hundreds of lawsuits.

A bill that would revamp the way the Food and Drug Administration reviews and inspects drugs and medical devices has passed the Senate by a wide margin.

Lap-Band maker Allergan has been subpoenaed by the U.S. government over problems with the weight loss device.

A bid by tobacco companies to overrule a court judgment that they must do corrective advertising about the dangers of smoking received a chilly response from a federal appeals court Friday.

A federal appeals court Tuesday weighed the constitutionality of requiring large graphic photos on cigarette packs to show that smoking can disfigure and even kill people, with two of the three judges questioning how far the government could go.

A number of recent lawsuits filed by plaintiffs allege that companies are falsely advertising their products as “all natural” or “100 percent” natural when they in fact contain synthetic ingredients or genetically modified organisms.

The proposed fiscal 2013 budget released by the White House outlines a number of the administration’s priorities related to lawyers, from an increase in enforcement of federal employment and labor laws to more focused attention on food and drug safety and immigration enforcement.

A judge on Wednesday blocked a federal requirement that would have begun forcing U.S. tobacco companies to put large graphic images on their cigarette packages later this year to show the dangers of smoking and encouraging smokers to quit lighting up.

A bill introduced in the Senate is aimed at accelerating the Food and Drug Administration’s approval process for new drugs and treatments needed by patients with serious or life-threatening diseases.

The Food and Drug Administration and the medical device manufacturing industry have reached a tentative agreement on user fees under the reauthorization of the Medical Device User Fee Act.

Business groups are urging a federal court to uphold an order blocking the Food and Drug Administration from implementing a rule requiring tobacco product makers to place large, graphic warnings on product packaging.

The ingestion of Zoloft during pregnancy caused birth defects in the children of eight couples, according to a lawsuit filed in Illinois state court.

A judge on Monday blocked a federal requirement that would have begun forcing tobacco companies next year to put graphic images including dead and diseased smokers on their cigarette packages.